Medistim ASA Statistics

Total Valuation

Medistim ASA has a market cap or net worth of SEK 4.23 billion. The enterprise value is 4.07 billion.

Market Cap	4.23B
Enterprise Value	4.07B

Important Dates

The last earnings date was Tuesday, April 14, 2026.

Earnings Date	Apr 14, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	18.29M
Shares Outstanding	n/a
Shares Change (YoY)	-0.21%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	2.94%
Owned by Institutions (%)	83.62%
Float	12.55M

Valuation Ratios

The trailing PE ratio is 29.06 and the forward PE ratio is 27.50.

PE Ratio	29.06
Forward PE	27.50
PS Ratio	6.61
PB Ratio	9.88
P/TBV Ratio	12.10
P/FCF Ratio	25.48
P/OCF Ratio	24.73
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.32, with an EV/FCF ratio of 24.51.

EV / Earnings	27.95
EV / Sales	5.86
EV / EBITDA	19.32
EV / EBIT	20.89
EV / FCF	24.51

Financial Position

The company has a current ratio of 3.34, with a Debt / Equity ratio of 0.11.

Current Ratio	3.34
Quick Ratio	2.16
Debt / Equity	0.11
Debt / EBITDA	0.23
Debt / FCF	0.27
Interest Coverage	360.66

Financial Efficiency

Return on equity (ROE) is 35.18% and return on invested capital (ROIC) is 51.38%.

Return on Equity (ROE)	35.18%
Return on Assets (ROA)	19.85%
Return on Invested Capital (ROIC)	51.38%
Return on Capital Employed (ROCE)	37.92%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	4.02M
Profits Per Employee	915,555
Employee Count	159
Asset Turnover	1.13
Inventory Turnover	0.80

Taxes

In the past 12 months, Medistim ASA has paid 43.56 million in taxes.

Income Tax	43.56M
Effective Tax Rate	23.03%

Stock Price Statistics

The stock price has increased by +45.34% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+45.34%
50-Day Moving Average	221.84
200-Day Moving Average	n/a
Relative Strength Index (RSI)	55.49
Average Volume (20 Days)	219

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medistim ASA had revenue of SEK 639.83 million and earned 145.57 million in profits. Earnings per share was 7.96.

Revenue	639.83M
Gross Profit	522.63M
Operating Income	179.39M
Pretax Income	189.13M
Net Income	145.57M
EBITDA	185.98M
EBIT	179.39M
Earnings Per Share (EPS)	7.96

Balance Sheet

The company has 193.92 million in cash and 45.05 million in debt, giving a net cash position of 148.87 million.

Cash & Cash Equivalents	193.92M
Total Debt	45.05M
Net Cash	148.87M
Net Cash Per Share	n/a
Equity (Book Value)	428.29M
Book Value Per Share	23.43
Working Capital	305.86M

Cash Flow

In the last 12 months, operating cash flow was 171.06 million and capital expenditures -5.02 million, giving a free cash flow of 166.04 million.

Operating Cash Flow	171.06M
Capital Expenditures	-5.02M
Depreciation & Amortization	7.17M
Net Borrowing	-9.32M
Free Cash Flow	166.04M
FCF Per Share	n/a

Margins

Gross margin is 81.68%, with operating and profit margins of 28.04% and 22.75%.

Gross Margin	81.68%
Operating Margin	28.04%
Pretax Margin	29.56%
Profit Margin	22.75%
EBITDA Margin	29.07%
EBIT Margin	28.04%
FCF Margin	25.95%

Dividends & Yields

Medistim ASA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	68.76%
Buyback Yield	0.21%
Shareholder Yield	0.21%
Earnings Yield	3.44%
FCF Yield	3.92%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medistim ASA has an Altman Z-Score of 15.37 and a Piotroski F-Score of 6.

Altman Z-Score	15.37
Piotroski F-Score	6